Scynexis (SCYX) Other Non-Current Liabilities (2013 - 2026)
Scynexis (SCYX) reported Other Non-Current Liabilities of $18.9 million for Q1 2026, up 272.03% on a YoY basis from $5.1 million in Q1 2025, and up 747.73% quarter-over-quarter from $2.2 million in Q4 2025.
Scynexis (SCYX) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Scynexis has reported Other Non-Current Liabilities for 13 years, with the latest figure at $18.9 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 272.03% year-over-year to $18.9 million; the trailing twelve-month figure through Mar 2026 stood at $18.9 million (up 272.03% YoY), and the FY2025 full-year result was $2.2 million, down 72.18% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $18.9 million, up from $2.2 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $40.3 million in Q1 2023, with the low at $2.2 million in Q4 2025.
- Historically, Other Non-Current Liabilities has averaged $14.7 million across 5 years, with a median of $12.2 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 457.37% — and 2025, when it plunged 83.83%.
- Scynexis' Other Non-Current Liabilities stood at $18.6 million in 2022, then climbed by 16.28% to $21.7 million in 2023, then tumbled by 63.11% to $8.0 million in 2024, then plunged by 72.18% to $2.2 million in 2025, then soared by 747.73% to $18.9 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $18.9 million (Q1 2026), $2.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.86 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 5.07 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 11.21 Mn |
| Jun 30, 2024 | 17.96 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2023 | 21.68 Mn |
| Sep 30, 2023 | 23.64 Mn |
| Jun 30, 2023 | 30.09 Mn |
| Mar 31, 2023 | 40.32 Mn |
| Dec 31, 2022 | 18.64 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 21.23 Mn |
| Mar 31, 2022 | 7.92 Mn |
| Dec 31, 2021 | 3.35 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 24.45 Mn |